The Medicines Patent Pool (MPP) was established in 2010 to ensure timely access to low-cost generic versions of patented antiretroviral (ARV) medicines in low-and middle-income countries (LMICs) through the negotiation of voluntary licenses with patent holders. While robust data on the savings...